Sector: MedicalRepligen Corporation (NASDAQ: RGEN)
Headlines
- Repligen Reports Second Quarter Fiscal Year 2010 Financial Results
Nov 05, 2009 07:01 AM | BMY, RGEN
- Repligen to Present at the Merriman Curhan Ford 6th Annual Investor Summit Tuesday, November 10th, 1:40 p.m. EST
Nov 03, 2009 08:03 AM | RGEN
- Repligen Announces Conference Call of Second Quarter Fiscal Year 2010 Results
Oct 29, 2009 08:01 AM | RGEN
- Families of Spinal Muscular Atrophy Licenses Potential Treatment for SMA to Repligen Corporation
Oct 22, 2009 04:01 PM | RGEN
- Repligen Licenses Potential Treatment for Spinal Muscular Atrophy
Oct 22, 2009 04:00 PM | RGEN
- Repligen Announces Completion of Patient Treatment in Phase 3 Clinical Trial of RG1068 in MRI Imaging of the Pancreas
Oct 19, 2009 01:00 PM | RGEN
- Repligen Announces Identification of Drug Target for Friedreich's Ataxia
Sep 25, 2009 12:15 PM | RGEN
- Repligen to Present at the Rodman & Renshaw 11th Annual Healthcare Conference Wednesday, September 9th, 2:25 p.m. EDT
Sep 02, 2009 08:01 AM | RGEN
- 3SBio Inc. Announces Filing of Annual Report on Form 20-F and Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
Jul 02, 2008 09:00 AM | PPHM, RGEN, SSRX
- TapImmune Issued U.S. Patent Relating to Methods for Enhancing an Immune Response and Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
Jun 30, 2008 10:30 AM | ANIK, CXM, RGEN
- Repligen Elects Glenn L. Cooper, M.D. To the Board of Directors
Aug 25, 2009 07:57 AM | LLY, RGEN
- Repligen Reports First Quarter Fiscal Year 2010 Financial Results
Aug 06, 2009 07:01 AM | RGEN
- Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results
Jul 30, 2009 08:01 AM | RGEN
- Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Jun 11, 2009 07:52 AM | RGEN
- Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results
Jun 04, 2009 08:01 AM | RGEN
- Repligen Licenses Patent Rights for Treatment of Bipolar Disorder
Mar 31, 2009 12:28 PM | RGEN
- Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT
Mar 09, 2009 08:00 AM | RGEN
- Repligen Announces ISO 9001:2000 Certification
Feb 12, 2009 08:04 AM | RGEN
- Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
Feb 05, 2009 07:01 AM | RGEN
- Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
Feb 02, 2009 09:09 AM | RGEN
- Form 4 REPLIGEN CORP For: Nov 09 Filed by: COOPER GLENN L MD (10K)
Nov 17, 2009 05:36 PM
- Form 4 COOPER GLENN L MD For: Aug 24 (10K)
Aug 25, 2009 06:51 PM
- Form 3 COOPER GLENN L MD For: Aug 25 (10K)
Aug 25, 2009 06:36 PM
- Form 4 LAMPERT MARK N For: Jul 06 (10K)
Jul 08, 2009 07:49 PM
- Form 3 LAMPERT MARK N For: May 15 (10K)
May 20, 2009 06:23 PM
- Form 4 RYAN THOMAS F JR For: Sep 12 (10K)
Apr 30, 2009 04:35 PM
- Form 4 Goldberg Alfred Lewis For: Sep 12 (10K)
Apr 30, 2009 04:23 PM
- Form 4 Henry Earl Webb For: Sep 12 (10K)
Apr 30, 2009 04:15 PM
- Form 4 REPLIGEN CORP For: Sep 12 Filed by: DAWES KAREN A (10K)
Apr 30, 2009 04:04 PM
- Form 4 Benjamin Howard For: Jan 05 (10K)
Jan 07, 2009 09:31 AM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
RGEN
|
Compare to S&P
|
| YTD |
25.93 %
|
4.22 %
|
| 4 Weeks |
-4.99 %
|
-6.02 %
|
| 12 Weeks |
-6.11 %
|
-11.49 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 25.00 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: 7.11 %
|
|
Sales Growth in Last Quarter: 6.50 %
|
|
